Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07126990) titled 'Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma' on Aug. 11.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Xiaorong Wu
Condition:
Non-functional Primary High-Grade Gliomas
Intervention:
Biological: Novel oncolytic virus Ad-TD-nsIL12
Recruitment Status: Recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: February 12, 2025
Target Sample Size: 40
Countries of Recruitment:
China
To know more, visit https://clinicaltri...